Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on Veto of Prescription Drug…
Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB)…
Learn more
BIO Statement on Resignation of FDA Commissioner…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE…
Learn more
BIO Launches “The Fight of Our Lives,” a National…
WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of ​​The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Elects New Board Directors and Re-Elects Section Governing Board Chairs
June 14, 2022
The Biotechnology Innovation Organization (BIO) is pleased to announce the election of its new Executive Committee directors for the 2022-2023 term. BIO’s Board elections took place Monday, June 13 during the 2022 BIO International Convention…
The Licensing of Academic Patents Contributed Up to $1.9 Trillion to the US Economy, Supported up to 6.5 Million Jobs in the last 25 Years New Report Highlights the Importance of Research and Public-Private Partnerships
June 14, 2022
The licensing of university and nonprofit research has made a significant contribution to US gross domestic product (GDP), industrial gross output, and jobs over the last 25 years and underscores the importance of basic and applied research to the…
Third-Annual Report on Diversity, Equity, and Inclusion in Biotechnology Finds Improvements in Gender Parity; More Progress Needed in Racial and Ethnicity Representation
June 13, 2022
The third annual report that examines diversity, equity, and inclusion (DEI) in the biotechnology industry launched today at the 2022 BIO International Convention. The report, “Measuring Diversity in the Biotech Industry: Tracking Progress in Small…
Do You Know a Game-Changer in the Bioeconomy? Nominations for BIO’s Prestigious Innovation Awards Open Today
June 8, 2022
The Biotechnology Innovation Organization today announced the opening of nominations for two awards to honor significant leaders driving cutting-edge, sustainable breakthroughs in the fields of agriculture and the environment.  The George…
Do You Know a Game-Changer in the Bioeconomy? Nominations for BIO’s Prestigious Innovation Awards Open Today
June 8, 2022
The Biotechnology Innovation Organization today announced the opening of nominations for two awards to honor significant leaders driving cutting-edge, sustainable breakthroughs in the fields of agriculture and the environment. BIO will accept…
LIVE from Space: It’s Out-of-This-World Biotech Research
June 3, 2022
NASA Astronaut Kjell Lindgren, MD, will connect live from the International Space Station to the Biotechnology Innovation Organization’s BIO International Convention on June 14. While the world’s largest biotechnology meeting will take place in…
Dr. Michelle McMurry-Heath Statement on Recent Gun Violence
May 27, 2022
Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement responding to recent incidences of gun violence across the country: "I couldn’t sleep last night. It has been an…
Olympian and Grand Slam Champion Venus Williams and Sportscasting Legend Erin Andrews Share Their Patient Perspectives with Biotech Community
May 19, 2022
Seven-time Grand Slam singles champion, four-time Olympic gold medalist and entrepreneur Venus Williams will discuss her groundbreaking career, business success, and health journey in a conversation with Emmy-nominated sports reporter Erin Andrews…
BIO Response to Second Global COVID-19 Summit
May 12, 2022
The White House today hosted world leaders and key public and private sector partners at the second Global COVID-19 Summit, a virtual event. Following the conversation, Dr. Michelle McMurry-Heath, President and CEO of the…
BIO Statement on New PDUFA Package
May 4, 2022
The House Energy & Commerce Committee today unveiled a new package for the Prescription Drug User Fee Act (PDUFA). After the release, BIO’s Chief Science Officer, Cartier Esham, made the following remarks:  "For more than thirty years, the…